ArticleClinical ophthalmology (Auckland, N.Z.)2022

The DEPOT Study (Dry Eye Prescription Options for Therapy): Assessing the Efficacy and Safety of OTX-DED (Dexamethasone Ophthalmic Insert 0.3 mg) for Intracanalicular Use Compared with Loteprednol Suspension for the Treatment of Episodic Dry Eye.

John A Hovanesian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.